Company code: Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) company abbreviation: Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513)
Annual report for 2021
Important tips
1、 The board of directors, board of supervisors, directors, supervisors and senior managers of the company guarantee the authenticity, accuracy and integrity of the contents of the annual report, and there are no false records, misleading statements or major omissions, and bear individual and joint legal liabilities. 2、 III. when the company is not profitable and not yet listed √ yes
The company has described in detail various risks and countermeasures that the company may face in the process of production and operation in this report. Please refer to “IV. risk factors” in Section III “management discussion and analysis”. Investors are kindly requested to pay attention and pay attention to investment risks. 4、 All directors of the company attended the board meeting. 5、 Zhonghui Certified Public Accountants (special general partnership) issued a standard unqualified audit report for the company. 6、 Wang Ying, the person in charge of the company, Xiong Changjian, the person in charge of accounting, and Bo Xiaoqin, the person in charge of the accounting organization (Accounting Supervisor), declare that they guarantee the authenticity, accuracy and completeness of the financial report in the annual report. 7、 The profit distribution plan or the plan of converting accumulation fund into share capital in the reporting period adopted by the resolution of the board of directors
After deliberation at the second meeting of the third board of directors of the company, the profit distribution plan of the company for 2021 is proposed as follows: Taking the total share capital of the company as 120090000 shares at the end of the reporting period as the base, distribute cash dividends of RMB 7.8 (tax included) to all shareholders for every 10 shares, and distribute cash dividends of RMB 93670200 (tax included) in total; The company does not give bonus shares or convert capital reserve into share capital.
The profit distribution plan can only be implemented after being deliberated and approved by the company’s 2021 annual general meeting of shareholders. 8、 Whether there are important matters such as special arrangements for corporate governance □ applicable √ not applicable IX. risk statement of forward-looking statements √ applicable □ not applicable
The company’s future plans, development strategies and other forward-looking statements involved in this report do not constitute the company’s substantive commitment to investors. Investors are reminded to pay attention to investment risks. 10、 Is there any non operational occupation of funds by the controlling shareholders and their related parties? No
11、 Whether there is any external guarantee in violation of the specified decision-making procedures? No 12. Whether more than half of the directors cannot guarantee the authenticity, accuracy and integrity of the annual report disclosed by the company? No 13. Others □ applicable √ not applicable
catalogue
Section 1 interpretation Section 2 company profile and main financial indicators Section III Management Discussion and Analysis Section 4 corporate governance Section V environment, social responsibility and other corporate governance 86 section VI important matters Section VII changes in shares and shareholders 128 Section VIII preferred shares Section IX corporate bonds 137 section x financial report one hundred and thirty-eight
(I) financial report containing the signatures and seals of the company’s principal, the person in charge of accounting work and the person in charge of accounting institution.
The catalogue of documents for future reference (II) contains the original audit report sealed by the accounting firm and signed and sealed by the certified public accountant.
(III) the text of all company documents and the original version of the announcement publicly disclosed on the website designated by the CSRC during the reporting period.
Section I interpretation
1、 Interpretation
In this report, unless the context otherwise requires, the following words have the following meanings: Interpretation of common words
The company, the company and Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) refer to Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513)
Sichuan sunshine refers to Sichuan sunshine Runhe Pharmaceutical Co., Ltd., which is a wholly-owned subsidiary of the company
Qingmu pharmaceutical refers to Sichuan Qingmu Pharmaceutical Co., Ltd., which is a wholly-owned subsidiary of the company
Tibet Runhe refers to Tibet Runhe Pharmaceutical Co., Ltd., which is a wholly-owned subsidiary of the company
Shuoder pharmaceutical refers to Chengdu shuoder Pharmaceutical Co., Ltd., which is a wholly-owned subsidiary of the company
Chengdu Youluo Biotechnology Co., Ltd. refers to Chengdu Youluo Biotechnology Co., Ltd., which is a wholly-owned subsidiary of the company
Youluo biological Shanghai refers to Youluo biological (Shanghai) Co., Ltd., which is a wholly-owned subsidiary of the company
Shanghai Senbo refers to Shanghai Senbo Investment Co., Ltd
Zhuyuan investment refers to Chengdu Zhuyuan investment partnership (limited partnership)
Nanyuan investment refers to Chengdu Nanyuan investment partnership (limited partnership)
Juyuan investment refers to Chengdu Juyuan investment partnership (limited partnership)
Jibai management refers to Jibai (Shanghai) Enterprise Management Consulting Co., Ltd
Puzhong Xincheng refers to Puzhong Xincheng asset management (Beijing) Co., Ltd
Rongyuan investment refers to Beijing Rongyuan investment partnership (limited partnership)
Citic Securities Company Limited(600030) investment refers to Citic Securities Company Limited(600030) Investment Co., Ltd
Chaxi think tank refers to Shenzhen Qianhai chaxi think tank No. 2 equity investment partnership (limited partnership)
Defu investment refers to Guangzhou Defu phase II equity investment fund (limited partnership)
Nantong dongtuo refers to Nantong dongtuo venture capital enterprise (limited partnership)
Beijing time investment refers to Beijing time investment partnership (limited partnership)
Beijing Runhe and Beijing Sunshine refer to Beijing Sunshine Runhe Technology Co., Ltd
Beijing Cain refers to Beijing Cain Geling Biotechnology Co., Ltd
The State Drug Administration refers to the State Drug Administration
FDA means the U.S. Food and drug administration
GMP refers to the good manufacturing practice
Nmpa means the State Drug Administration
Current good manufacturing practices (CGMP), an international drug production management standard, requires verification in the whole process of product production and logistics
CEP refers to the certification of the applicability of the European Pharmacopoeia. The European drug quality administration has initiated an independent quality evaluation procedure for the API that has been included in the European Pharmacopoeia
MF refers to the master document registration system of pharmaceutical raw and auxiliary materials in Japan
Over the counter drugs refer to the drugs that can be purchased without the prescription of doctors or other medical professionals on the premise of ensuring the safety of drug use and after being stipulated or approved by the national OTC health administrative department
Contract manufacturing organization, a contract production business organization, is mainly entrusted by a pharmaceutical company to provide process development, formula development, clinical trial drugs, chemical or biosynthetic API production, intermediate manufacturing, pharmaceutical manufacturing and other businesses required for product production
Cdmo refers to the contract development and manufacturing organization, the contract R & D and production business organization, that is to add customized R & D business of relevant products on the basis of CMO
Ind refers to the abbreviation of investigational new drug in English. The main purpose of IND is to provide sufficient information to prove that the drug is safe to be tested in human body and to prove the clinical efficacy for research purposes
The bed scheme design is reasonable.
Anda stands for abbreviated new drug application in English. Anda’s application is to “copy” a product that has been approved for listing
CGT refers to the abbreviation of competitive generic therapies in English, that is, competitive generic therapies in the United States. Drugs with CGT qualification can enhance and speed up the review by simplifying new drug applications
The active substance master file (ASMF), commonly known as the European drug master file (edmf), is applicable to the identified active substances with ASMF. Edmf can only be submitted if it is used to support a MAA or MAV
DMF refers to drugmasterfile, the drug master file, and the document to be submitted when applying for drug registration with FDA
General meeting of shareholders refers to Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) general meeting of shareholders
Board of directors means Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) board of directors
Board of supervisors refers to Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) board of supervisors
3. Board of directors refers to the general meeting of shareholders, the board of directors and the board of supervisors
CSRC refers to the China Securities Regulatory Commission
Exchange means Shanghai Stock Exchange
Scientific innovation board refers to the scientific innovation board of Shanghai Stock Exchange
Company Law refers to the company law of the people’s Republic of China
The articles of association refers to the Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) articles of association
The Listing Rules refer to the Listing Rules of Shanghai Stock Exchange’s Sci tech innovation board
The reporting period refers to January December 2021
The end of the reporting period refers to December 31, 2021
Yuan, ten thousand yuan and one hundred million yuan refer to RMB, ten thousand yuan and one hundred million yuan
Section II Company Profile and main financial indicators
1、 Basic information of the company
Chinese name of the company Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513)
Chinese abbreviation of the company Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513)
The foreign language name of the company is Chengdu Easton biopharmaceuticals Co, Ltd.
Abbreviation of foreign name of the company
